NLF-PD-1233

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameNLF-PD-1233
Drug Alias NameASO-1233 (nLife Therapeutics)alpha synuclein modulator (nLife Therapeutics)NLF-1233NLF-PDNLF-PD-1233
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense
Mechanisms of ActionSynuclein alpha inhibitorsAntisense oligonucleotide inhibitors
TargetsSynuclein alpha
Therapy Area/IndicationsParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySpain
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesnLife Therapeutics SL
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesnLife Therapeutics SL
Active IndicationsN/A
Inactive IndicationsParkinson Disease

Other Information

ATC CodeN/A
Related LinksN/A